Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis

Cell Death and Disease

Volumn 3, Issue 6, 2012, Pages

  Madonna, S ^a   Scarponi, C ^a   Pallotta, S ^a   Cavani, A ^a   Albanesi, C ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

keratinocyte apoptosis; pro survival AKT pathway; psoriasis; SOCS molecules

Indexed keywords

GAMMA INTERFERON; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN KINASE B; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RAS PROTEIN; SOCS1 PROTEIN, HUMAN; SOCS3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; CYTOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

APOPTOSIS; HUMANS; INTERFERON-GAMMA; KERATINOCYTES; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PSORIASIS; RAS PROTEINS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSFECTION;

EID: 84863462044     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.69     Document Type: Article

References (40)

1. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007; 7: 454-465.
2. Dimitriou ID, Clemenza L, Scotter AJ, Chen G, Guerra FM, Rottapel R. Putting out the fire: Coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol Rev 2008; 224: 265-283.
3. Ramana CV, Gil MP, Schreiber RD, Stark GR. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol 2002; 23: 96-101.
4. Federici M, Giustizieri ML, Scarponi C, Girolomoni G, Albanesi C. Impaired IFN-gammadependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1. J Immunol 2002; 169: 434-442.
5. Madonna S, Scarponi C, De Pita' O, Albanesi C. Suppressor of cytokine signaling 1 inhibits IFN-gamma inflammatory signaling in human keratinocytes by sustaining ERK1/2 activation. FASEB J 2008; 22: 3287-3297.
6. Madonna S, Scarponi C, Sestito R, Pallotta S, Cavani A, Albanesi C. The IFN-gammadependent suppressor of cytokine signaling 1 promoter activity is positively regulated by IFN regulatory factor-1 and Sp1 but repressed by growth factor independence-1b and Krüppel-like factor-4, and it is dysregulated in psoriatic keratinocytes. J Immunol 2010; 185: 2467-2481.
7. Doti N, Scognamiglio PL, Madonna S, Scarponi C, Ruvo M, Perretta G et al. New mimetic peptides of Kinase Inhibitory Region (KIR) of SOCS1 through focused peptide libraries. Biochem J 2012; 443: 231-240.
8. Strebovsky J, Walker P, Lang R, Dalpke AH. Suppressor of cytokine signaling 1 (SOCS1) limits NF kappa B signaling by decreasing p65 stability within the cell nucleus. FASEB J 2011; 25: 863-874.
9. He Y, Zhang W, Zhang R, Zhang H, Min W. SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation. J Biol Chem 2006; 281: 5559-5566.
10. Croker BA, Kiu H, Pellegrini M, Toe J, Preston S, Metcalf D et al. IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3. Immunol Cell Biol 2011; 26: 1-6.
11. van de Geijn GJ, Gits J, Touw IP. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling. J Leukoc Biol 2004; 76: 237-244.
12. Morita Y, Naka T, Kawazoe Y, Fujimoto M, Narazaki M, Nakagawa R et al. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/ suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. Proc Natl Acad Sci USA 2000; 97: 5405-5410.
13. Kimura A, Naka T, Nagata S, Kawase I, Kishimoto T. SOCS-1 suppresses TNF-Alpha-induced apoptosis through the regulation of Jak activation. Int Immunol 2004; 16: 991-999.
14. Bruun C, Heding PE, Rønn SG, Frobøse H, Rhodes CJ, Mandrup-Poulsen T et al. Suppressor of cytokine signalling-3 inhibits Tumor necrosis factor-Alpha induced apoptosis and signalling in beta cells. Mol Cell Endocrinol 2009; 311: 32-38.
15. Tomita S, Ishibashi K, Hashimoto K, Sugino T, Yanagida T, Kushida N et al. Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-A. Cancer Sci 2011; 102: 57-63.
16. Lippens S, Hoste E, Vandenabeele P, Agostinis P, Declercq W. Cell death in the skin. Apoptosis 2009; 14: 549-569.
17. Reefman E, Limburg PC, Kallenberg CG, Bijl M. Apoptosis in human skin: Role in pathogenesis of various diseases and relevance for therapy. Ann NY Acad Sci 2005; 1051: 52-63.
18. Raj D, Brash DE, Grossman D. Keratinocyte apoptosis in epidermal development and disease. J Invest Dermatol 2006; 126: 243-257.
19. Dallaglio K, Marconi A, Pincelli C. Survivin: A dual player in healthy and diseased skin. J Invest Dermatol 2012; 132: 18-27.
20. Fukuya Y, Higaki M, Higaki Y, Kawashima M. Effect of vitamin D3 on the increased expression of Bcl-xL in psoriasis. Arch Dermatol Res 2002; 293: 620-625.
21. Györffy B, Schäfer R. Biomarkers downstream of RAS: A search for robust transcriptional targets. Curr Cancer Drug Targets 2010; 10: 858-868.
22. Espada J, Galaz S, Sanz-Rodríguez F, Blázquez-Castro A, Stockert JC, Bagazgoitia L et al. Oncogenic H-Ras and PI3K signaling can inhibit E-cadherin-dependent apoptosis and promote cell survival after photodynamic therapy in mouse keratinocytes. J Cell Physiol 2009; 219: 84-93.
23. Kim NH, Jeon S, Lee HJ, Lee AY. Impaired PI3K/Akt activation-mediated NF-kappaB inactivation under elevated TNF-Alpha is more vulnerable to apoptosis in vitiliginous keratinocytes. J Invest Dermatol 2007; 127: 2612-2617.
24. Claerhout S, Decraene D, Van Laethem A, Van Kelst S, Agostinis P, Garmyn M. AKT delays the early-Activated apoptotic pathway in UVB-irradiated keratinocytes via BAD translocation. J Invest Dermatol 2007; 127: 429-438.
25. Kokolakis G, Giannikaki E, Stathopoulos E, Avramidis G, Tosca AD, Krüger-Krasagakis S. Infliximab restores the balance between pro- and anti-Apoptotic proteins in regressing psoriatic lesions. Br J Dermatol 2012; 166: 491-497.
26. Albanesi C, Pastore S. Pathobiology of chronic inflammatory skin diseases: Interplay between keratinocytes and immune cells as a target for anti-inflammatory drugs. Curr Drug Metab 2010; 11: 210-227.
27. Doger FK, Dikicioglu E, Ergin F, Unal E, Sendur N, Uslu M. Nature of cell kinetics in psoriatic epidermis. J Cutan Pathol 2007; 34: 257-263.
28. Wrone-Smith T, Mitra RS, Thompson CB, Jasty R, Castle VP, Nickoloff BJ. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol 1997; 151: 1321-1329.
29. Wrone-Smith T, Johnson T, Nelson B, Boise LH, Thompson CB, Núnez G et al. Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am J Pathol 1995; 146: 1079-1088.
30. Di Meglio P, Perera GK, Nestle FO. The multitasking organ: Recent insights into skin immune function. Immunity 2011; 35: 857-869.
31. Albanesi C, De Pità O, Girolomoni G. Resident skin cells in psoriasis: A special look at the pathogenetic functions of keratinocytes. Clin Dermatol 2007; 25: 581-588.
32. Zheng Y, Danilenko D M, Valdez P, Kasman I, Eastham- Anderson J, Wu J et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445: 648-651.
33. Qin JZ, Chaturvedi V, Denning MF, Choubey D, Diaz MO, Nickoloff BJ. Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes. J Biol Chem 1999; 274: 37957-37964.
34. Wolk K, Haugen HS, Xu W, Witte E, Waggie K, Anderson M et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med 2009; 87: 523-536.
35. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009; 119: 3573-3585.
36. Schieke SM, von Montfort C, Buchczyk DP, Timmer A, Grether-Beck S, Krutmann J et al. Singlet oxygen-induced attenuation of growth factor signaling: Possible role of ceramides. Free Radic Res 2004; 38: 729-737.
37. Lin J, Guan Z, Wang C, Feng L, Zheng Y, Caicedo E et al. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin Cancer Res 2010; 16: 77-87.
38. Bai S, Liu H, Chen KH, Eksarko P, Perlman H, Moore TL et al. NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis. Arthritis Rheum 2004; 50: 3844-3855.
39. Kwon HK, Hwang JS, So JS, Lee CG, Sahoo A, Ryu JH et al. Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1. BMC Cancer 2010; 10: 392-402.
40. Samuels Y, Ericson K. Oncogenic PI3K and its role in cancer. Curr Opin Oncol 2006; 18: 77-82.